Joseph Klein III, Director at IONIS PHARMACEUTICALS INC (IONS), sold 1,333 shares at $37.74 ($51K) on 2022-07-15, disclosed to the SEC on 2022-07-19.
Scheduled sale ($51k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.74 | 689 | $26K | 51.0% |
| 2 | $38.78 | 644 | $25K | 49.0% |
| Total | $38.24 avg | 1,333 | $51K | 100% |
| Filing → |
| IONS | SELL | 2026-04-02 | $1.7M | — | Filing → |
| IONS | SELL | 2026-03-05 | $3.4M | — | Filing → |
| IONS | SELL | 2025-11-28 | $320K | — | Filing → |